Cascade Investment Group Inc. lifted its position in Procter & Gamble Company (The) (NYSE:PG – Free Report) by 10.9% during the 2nd quarter, according to the company in its most recent filing with the SEC. The fund owned 3,725 shares of the company’s stock after purchasing an additional 367 shares during the quarter. Cascade Investment Group Inc.’s holdings in Procter & Gamble were worth $593,000 at the end of the most recent reporting period.
A number of other institutional investors have also made changes to their positions in the business. Nova Wealth Management Inc. bought a new position in shares of Procter & Gamble in the first quarter valued at about $26,000. Signature Resources Capital Management LLC raised its holdings in shares of Procter & Gamble by 67.9% in the second quarter. Signature Resources Capital Management LLC now owns 178 shares of the company’s stock valued at $28,000 after buying an additional 72 shares during the last quarter. Quarry LP bought a new position in shares of Procter & Gamble in the first quarter valued at about $33,000. Mizuho Securities Co. Ltd. raised its holdings in shares of Procter & Gamble by 566.7% in the first quarter. Mizuho Securities Co. Ltd. now owns 200 shares of the company’s stock valued at $34,000 after buying an additional 170 shares during the last quarter. Finally, RMG Wealth Management LLC bought a new position in shares of Procter & Gamble in the second quarter valued at about $37,000. 65.77% of the stock is owned by institutional investors.
Procter & Gamble Price Performance
Procter & Gamble stock opened at $149.69 on Friday. The firm has a market capitalization of $350.34 billion, a P/E ratio of 22.99, a PEG ratio of 3.99 and a beta of 0.36. Procter & Gamble Company has a 1 year low of $149.45 and a 1 year high of $180.43. The business has a 50-day moving average of $155.24 and a 200-day moving average of $159.53. The company has a current ratio of 0.70, a quick ratio of 0.49 and a debt-to-equity ratio of 0.49.
Insider Activity at Procter & Gamble
In other news, CEO Gary A. Coombe sold 10,194 shares of the business’s stock in a transaction dated Thursday, August 21st. The stock was sold at an average price of $158.16, for a total transaction of $1,612,283.04. Following the completion of the transaction, the chief executive officer directly owned 34,978 shares in the company, valued at approximately $5,532,120.48. The trade was a 22.57% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, insider Marc S. Pritchard sold 9,849 shares of the business’s stock in a transaction dated Tuesday, August 19th. The stock was sold at an average price of $157.27, for a total value of $1,548,952.23. Following the transaction, the insider owned 182,422 shares of the company’s stock, valued at $28,689,507.94. The trade was a 5.12% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders sold 149,763 shares of company stock worth $23,421,279. 0.20% of the stock is owned by company insiders.
Analyst Ratings Changes
A number of research firms recently issued reports on PG. UBS Group cut their price target on Procter & Gamble from $180.00 to $176.00 and set a “buy” rating for the company in a report on Wednesday. Barclays lowered their price objective on Procter & Gamble from $164.00 to $153.00 and set an “equal weight” rating for the company in a research report on Wednesday, October 1st. BNP Paribas reiterated an “outperform” rating and issued a $177.00 price objective on shares of Procter & Gamble in a research report on Friday, August 15th. JPMorgan Chase & Co. lowered their price objective on Procter & Gamble from $170.00 to $163.00 and set a “neutral” rating for the company in a research report on Friday. Finally, Wells Fargo & Company lowered their price objective on Procter & Gamble from $173.00 to $170.00 and set an “overweight” rating for the company in a research report on Thursday, September 25th. Eleven investment analysts have rated the stock with a Buy rating and nine have given a Hold rating to the company’s stock. According to MarketBeat, Procter & Gamble has a consensus rating of “Moderate Buy” and an average price target of $172.21.
Check Out Our Latest Stock Report on PG
Procter & Gamble Profile
Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.
Recommended Stories
- Five stocks we like better than Procter & Gamble
- Low PE Growth Stocks: Unlocking Investment Opportunities
- 3 Heavily Shorted Stocks That Could Pop on Rate Cuts
- Differences Between Momentum Investing and Long Term Investing
- Broadcom Gets Second $420 Target as CPO Win Boosts Outlook
- What Are Growth Stocks and Investing in Them
- PepsiCo’s Deep Discount Will Soon Evaporate: Buy It While You Can
Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Procter & Gamble Company (The) (NYSE:PG – Free Report).
Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.